新冠病毒病对死亡率的影响及对青少年和青年医疗保健的启示
Impact-of-COVID-19 on mortality and implications for adolescent and young-adult healthcare.
作者信息
Takefuji Yoshiyasu
机构信息
Faculty of Data Science, Musashino University, 3-3-3 Ariake Koto-ku, Tokyo 135-8181, Japan.
出版信息
Health Care Transit. 2023 Aug 21;1:100015. doi: 10.1016/j.hctj.2023.100015. eCollection 2023.
Abstract
This paper investigates the effect of COVID-19 on mortality in the child and adolescent population of five age groups. The CDC dataset was used for calculating the number of deaths by adolescent age group from 2015 to 2020. Results showed that the older the adolescent, the stronger the effect of COVID-19 on mortality. There is no significant impact of COVID-19 on mortality of three aged groups (1-4, 5-9 and 10-14). There is a significant impact of COVID-19 on mortality of two aged groups (15-19 and 20-24). The findings indicate that effective drugs should be used for protecting them against COVID-19 and for computational ethics.
摘要
本文调查了新冠病毒病对五个年龄组儿童和青少年人群死亡率的影响。美国疾病控制与预防中心（CDC）数据集用于计算2015年至2020年各青少年年龄组的死亡人数。结果显示，青少年年龄越大，新冠病毒病对死亡率的影响越强。新冠病毒病对三个年龄组（1 - 4岁、5 - 9岁和10 - 14岁）的死亡率没有显著影响。新冠病毒病对两个年龄组（15 - 19岁和20 - 24岁）的死亡率有显著影响。研究结果表明，应使用有效药物来保护他们免受新冠病毒病感染，并用于计算伦理学。
相似文献
1
Impact-of-COVID-19 on mortality and implications for adolescent and young-adult healthcare.新冠病毒病对死亡率的影响及对青少年和青年医疗保健的启示
Health Care Transit. 2023 Aug 21;1:100015. doi: 10.1016/j.hctj.2023.100015. eCollection 2023.
2
Assessing COVID-19 Mortality in Serbia's Capital: Model-Based Analysis of Excess Deaths.评估塞尔维亚首都的新冠疫情死亡率：基于模型的超额死亡分析
JMIR Public Health Surveill. 2025 Apr 17;11:e56877. doi: 10.2196/56877.
3
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].[国家重点污染场地居民流行病学研究。第六次报告]
Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003.
4
5
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计，以及 COVID-19 大流行的影响：2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
6
Excess mortality in Israel associated with COVID-19 in 2020-2021 by age group and with estimates based on daily mortality patterns in 2000-2019.2020-2021 年以色列与 COVID-19 相关的超额死亡率按年龄组划分，并根据 2000-2019 年的每日死亡率模式进行估计。
Int J Epidemiol. 2022 Jun 13;51(3):727-736. doi: 10.1093/ije/dyac047.
7
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.全球、区域和国家在实现世卫组织 2020 年结核病战略里程碑方面的年龄特定进展：2021 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Jul;24(7):698-725. doi: 10.1016/S1473-3099(24)00007-0. Epub 2024 Mar 19.
8
Non-COVID-19 excess deaths by age and gender in the United States during the first three months of the COVID-19 pandemic.美国 COVID-19 大流行前三个月按年龄和性别划分的非 COVID-19 超额死亡人数。
Public Health. 2020 Dec;189:101-103. doi: 10.1016/j.puhe.2020.10.004. Epub 2020 Oct 10.
9
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析：全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
10
Impact of COVID-19 infection on life expectancy, premature mortality, and DALY in Maharashtra, India.印度马哈拉施特拉邦 COVID-19 感染对预期寿命、过早死亡和伤残调整生命年的影响。
BMC Infect Dis. 2021 Apr 12;21(1):343. doi: 10.1186/s12879-021-06026-6.
本文引用的文献
1
Impact of COVID-19 on mortality under 5 years old.COVID-19 对 5 岁以下儿童死亡率的影响。
Pediatr Res. 2023 Nov;94(5):1592. doi: 10.1038/s41390-023-02612-3. Epub 2023 Apr 17.
2
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.新冠病毒感染发病率、严重程度和死亡率的风险和保护因素。
Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19.
3
Transition Planning for Chronic Illnesses in the Time of COVID-19.新冠疫情期间慢性病的过渡计划
J Patient Exp. 2020 Dec;7(6):848-850. doi: 10.1177/2374373520978875. Epub 2020 Dec 3.
4
Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020.由于对 COVID-19 的担忧而延迟或避免就医-美国，2020 年 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257. doi: 10.15585/mmwr.mm6936a4.
5
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.欧洲儿童和青少年中的 COVID-19：一项多国家、多中心队列研究。
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661. doi: 10.1016/S2352-4642(20)30177-2. Epub 2020 Jun 25.
6
Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.系统回顾儿童 COVID-19 病例表明，其症状比成人轻，预后也更好。
Acta Paediatr. 2020 Jun;109(6):1088-1095. doi: 10.1111/apa.15270. Epub 2020 Apr 14.
7
World Health Organization Guidance on Ethical Considerations in Planning and Reviewing Research Studies on Sexual and Reproductive Health in Adolescents.世界卫生组织关于青少年性与生殖健康研究规划与审查中伦理考量的指南。
J Adolesc Health. 2019 Apr;64(4):427-429. doi: 10.1016/j.jadohealth.2019.01.008.
8
The age of adolescence.青春期。
Lancet Child Adolesc Health. 2018 Mar;2(3):223-228. doi: 10.1016/S2352-4642(18)30022-1. Epub 2018 Jan 30.
9
Adolescence as a unique developmental period.青春期是一个独特的发育阶段。
J Psychiatry Neurosci. 2015 Sep;40(5):291-3. doi: 10.1503/jpn.150268.
10
Understanding normal development of adolescent sexuality: A bumpy ride.理解青少年性发育的正常过程：一段崎岖之路。
J Hum Reprod Sci. 2015 Apr-Jun;8(2):70-4. doi: 10.4103/0974-1208.158594.
Zotero 插件